CYTOSORBENTS CORPORATION Payments for Restructuring
CYTOSORBENTS CORPORATION (CTSO) reported Payments for Restructuring of $542.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2026-08-06
- CYTOSORBENTS CORPORATION payments for restructuring for the quarter ending 2026-06-30 was $229.00K.
- CYTOSORBENTS CORPORATION payments for restructuring for the quarter ending 2026-03-31 was $313.00K.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 12 month |
|---|---|---|---|
| 2026-06-30 | $229.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $542.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $313.00K 10-Q · filed 2026-05-13 | ||
| 2025-12-31 | $111.00K 10-Q · filed 2026-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |